Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | WHR1 | P49842 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.32 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.31 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21031636 | 1.00 | ATM (0.39) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031554 | 1.00 | ATM (0.39) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031658 | 0.99 | ATM (0.40) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031556 | 0.97 | ATM (0.41) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031143 | 0.97 | ATM (0.41) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031637 | 0.94 | MEN1 (0.36) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031670 | 0.94 | MEN1 (0.43) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21032248 | 0.94 | MEN1 (0.34) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031561 | 0.94 | MEN1 (0.39) | ATMMEN1KMT2AWHR1PTGER4 | |
| SCHEMBL21031547 | 0.94 | MEN1 (0.39) | ATMMEN1KMT2AWHR1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190161485-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | SOULBRAIN CO., LTD. (KR) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190161485-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE | DRD1, NR2E3, CRY1 | ATM 3334/4885MEN1 3006/4885KMT2A 2841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.